ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: FR-PO1023

Action of 3-Hydroxymethylglutaryl CoA Reductase Inhibitors on ABCA-1 Protein (ATP-Binding Cassette Transporter-1) in Endothelial Cells Stimulated with Uremic Serum

Session Information

Category: CKD (Non-Dialysis)

  • 2303 CKD (Non-Dialysis): Mechanisms


  • Batista, Marcelo Costa, Universidade Federal de Sao Paulo, São Paulo, Sao Paulo, Brazil
  • Quinto, Beata M r, Universidade Federal de Sao Paulo, São Paulo, Sao Paulo, Brazil

High incidence of cardiovascular events in chronic kidney disease (CKD) presents an epidemic character, including patients on predialysis, hemodialysis and post-transplant patients covering about 50% of deaths, with a mortality rate around 9% per year. The statins have been used primarily in the treatment of dyslipidemia and have pleiotropic effects not fully elucidated, as well as, there is no evidence to support its use for attenuation of the cardiovascular outcome and its potential action on ABCA-1 transporter modulation in DRC.
Thus, our aim was to verify the effect of statins on ABCA-1 modulation in cells culture of human umbilical vein (HUVEC) incubated with uremic serum from CKD patients.


Human umbilical cord vein endothelial cells (HUVEC) were pretreated with simvastatin and incubated with uremic serum. All groups were incubated for 24 hours at 37oC, under ideal conditions of humidity and CO2 concentration.
Expression of LxR α, LxRβ, RxR-α, and ABCA-1 was performed by real-time PCR, the levels of Interleukin 10 and TNF-α in the cell supernatant were measured by enzyme immunoassay, using the ELISA kit. Transfection of HUVEC cells was performed for analysis of promoter activation mediated by LxR and RxR-reporter gene and the expression of LxRβ, RxRα and ABCA1 evaluated by Western Blott.


We demonstrate that statins act on the inflammatory response of HUVEC cells exposed to the uremic environment by decreasing TNF-α secretion when compared to basal secretion. Our results suggest that the uremic environment reduces the expression of LxR-β and RxR-α leading to a consequent decrease in ABCA-1 expression in HUVEC. Pretreatement of endothlial cellwith simvastatin showed increased expression of ABCA-1, LxR-β and RxR-α, as well as the transcription of ABCA-1, LXR-β and RxR-α was significantly increased,


Our results suggests that statins may exert positive modulation on the LxR-β and RxR-α receptors for ABCA-1 transcription activation.


  • Government Support – Non-U.S.